EODData

LSE, 0WA2: Cellectis Ord Shs

07 Jul 2026
LAST:

2.720

CHANGE:
 0.13
OPEN:
2.820
HIGH:
2.820
ASK:
1.828
VOLUME:
1.9K
CHG(%):
4.53
PREV:
2.849
LOW:
2.720
BID:
1.740
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Jul 262.8202.8202.7202.7201.9K
06 Jul 262.8502.8532.8492.8492.1K
03 Jul 262.8382.8622.8382.8411.8K
02 Jul 262.7802.9302.7662.867125
01 Jul 262.6182.6182.5582.5842.5K
30 Jun 262.5242.7202.5242.603119
29 Jun 262.4902.4962.4462.496696
26 Jun 262.3972.4261.3862.426300
25 Jun 262.3962.4242.3962.424100
24 Jun 262.5482.5492.5482.548100

PROFILE

Name:Cellectis Ord Shs
About:Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company was founded in 1999 and is headquartered in Paris, France.
Address:8, rue de la Croix Jarry, Paris, France, 75013
Website:https://www.cellectis.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-10.08 
PEG Ratio:0.10 
Price to Sales:12.05 
Price to Book:3.67 
Profit Margin:0.78 
Operating Margin:-3.20 
Return on Assets:-0.18 
Return on Equity:-0.63 
Revenue:21.01M 

TECHNICAL INDICATORS

MA5:2.771.9%
MA10:2.643.2%
MA20:2.652.5%
MA50:2.958.5%
MA100:3.1114.2%
MA200:3.3623.4%
STO9:58.50
STO14:58.50
RSI14:50.95
WPR14:-33.18
MTM14:0.01
ROC14:0.00 
ATR:0.18 
Week High:2.937.7%
Week Low:2.527.8%
Month High:3.0311.5%
Month Low:1.3923.4%
Year High:4.8477.9%
Year Low:1.34103.4%